MedPath

Pneumatic Dilatation or Surgical Myotomy for Achalasia

Phase 2
Completed
Conditions
Achalasia
Interventions
Procedure: Laparoscopic myotomy
Procedure: Pneumatic dilatation
Registration Number
NCT02086669
Lead Sponsor
Karolinska University Hospital
Brief Summary

Patients with newly diagnosed achalasia have been submitted to either treatment with pneumatic dilatation or surgical myotomy. Minimal follow up five years.

Detailed Description

Patients with newly diagnosed achalasia have been submitted to either treatment with pneumatic dilatation or surgical myotomy. Minimal follow up five years.

During follow up patients have been interviewed with regular intervals, by use validated questionnaires. The level of symptom control has been assessed as well as the scoring cumulative incidence of treatment failures.

Health Related Quality of Life (HRQL) has been regularly checked.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
56
Inclusion Criteria
  • Newly diagnosed achalasia
  • Age 18-80 years
  • Informed consent
Exclusion Criteria
  • Previous treatment for achalasia.
  • Stage IV achalasia.
  • Unwillingness to participate.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Surgical myotomyLaparoscopic myotomyLaparoscopic myotomy and subsequent follow up.
Pneumatic dilatationPneumatic dilatationRepetitive pneumatic dilatation as the initial treatment followed by repetitive dilatation in case of dysphagia recurrence.
Primary Outcome Measures
NameTimeMethod
Treatment failuresAt least five years after intervention

Treatment failure is defined as a Composite variabel containing a number of different Clinically relevant outcomes.

Secondary Outcome Measures
NameTimeMethod
Dysphagia scoringAt least five years after intervention

Dysphagia score according to standardized, validated scoring system.

Health Related Quality of LifeAt least five years after intervention.

Universally adopted and validated instruments are used.

Direct medical costs.At least five years after intervention.

Charges for the average hospital in respective countries.

Trial Locations

Locations (1)

Sahlgrenska University Hospital

🇸🇪

Göteborg, Sweden

© Copyright 2025. All Rights Reserved by MedPath